TMO - Thermo Fisher Scientific Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 198.74B
Enterprise Value 230.52B
Trailing P/E 33.95
Forward P/E 21.88
PEG Ratio (5 yr expected) 3.84
Price/Sales (ttm)4.66
Price/Book (mrq)4.75
Enterprise Value/Revenue 5.26
Enterprise Value/EBITDA 21.09

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3-2.21%
S&P500 52-Week Change 310.08%
52 Week High 3611.06
52 Week Low 3475.77
50-Day Moving Average 3546.15
200-Day Moving Average 3546.06

Share Statistics

Avg Vol (3 month) 31.46M
Avg Vol (10 day) 32.05M
Shares Outstanding 5385.72M
Implied Shares Outstanding 6N/A
Float 8384.94M
% Held by Insiders 10.19%
% Held by Institutions 192.51%
Shares Short (May 14, 2023) 43.01M
Short Ratio (May 14, 2023) 41.87
Short % of Float (May 14, 2023) 40.78%
Short % of Shares Outstanding (May 14, 2023) 40.78%
Shares Short (prior month Apr 13, 2023) 42.95M

Dividends & Splits

Forward Annual Dividend Rate 41.4
Forward Annual Dividend Yield 40.27%
Trailing Annual Dividend Rate 31.25
Trailing Annual Dividend Yield 30.24%
5 Year Average Dividend Yield 40.22
Payout Ratio 48.15%
Dividend Date 3Jul 13, 2023
Ex-Dividend Date 4Jun 13, 2023
Last Split Factor 23:2
Last Split Date 3Jun 05, 1996

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 31, 2023


Profit Margin 13.75%
Operating Margin (ttm)17.05%

Management Effectiveness

Return on Assets (ttm)4.98%
Return on Equity (ttm)14.44%

Income Statement

Revenue (ttm)43.81B
Revenue Per Share (ttm)112.18
Quarterly Revenue Growth (yoy)-9.40%
Gross Profit (ttm)19B
Net Income Avi to Common (ttm)6.02B
Diluted EPS (ttm)15.33
Quarterly Earnings Growth (yoy)-41.80%

Balance Sheet

Total Cash (mrq)3.48B
Total Cash Per Share (mrq)9.03
Total Debt (mrq)35.34B
Total Debt/Equity (mrq)83.28
Current Ratio (mrq)1.27
Book Value Per Share (mrq)109.55

Cash Flow Statement

Operating Cash Flow (ttm)7.68B
Levered Free Cash Flow (ttm)4.6B